Hyperliquid Strategies Raises Share Buyback Authorization to $100 Million
Key Facts
Hyperliquid Strategies raised its share buyback authorization from $30 million to $100 million, leaving about $72 million available, according to a company announcement in October 2026. The board extended the program’s expiration date from December 5, 2026, to October 31, 2027. The amendment gives the company a higher limit and more time to buy PURR shares, which are listed on Nasdaq, as part of its treasury management framework. The company said the increase "reflects the board’s confidence in the company’s long-term capital allocation strategy" and provides flexibility to repurchase shares. The size of the authorization does not mean the company will spend the full amount, as the timing and volume of purchases remain at management’s discretion.
The amendment follows actual share purchases by the company during its fiscal year ended June 30, 2026. It acquired 3,067,097 treasury shares at a cost of $10.481 million during the year, according to its annual report filed with the U.S. Securities and Exchange Commission. Share repurchase payments totaled about $10.5 million, within net cash flows from financing activities of $934.5 million. These figures cover purchases during that fiscal year alone, while the new authorization describes the program’s maximum permitted amount after the amendment. The previous authorization was $30 million, making the increase to $100 million an expansion of the announced limit, not the value of completed purchases.
The program’s terms allow shares to be bought on the open market, through privately negotiated transactions or by other lawful means, according to the company’s annual disclosure. Management retains authority over the timing and size of purchases, and the board may extend, suspend or terminate the program. The authorization therefore does not set a fixed purchase schedule, even with its extension through October 31, 2027. The company said in its report that it may pursue buybacks when it believes the stock is trading at a material discount to its market net asset value. By contrast, it said it considers raising capital when it believes the stock is trading at a premium to that value, putting share repurchases and issuance among its capital allocation options tied to the company’s valuation.
The buyback policy is linked to the company’s shift to a digital asset-focused strategy and HYPE treasury. Chief Executive David Schamis said the company "more than doubled our HYPE treasury, launched a validator with others that quickly became one of the largest validators on the network, and completed our exit from our legacy biotech operations." The company said it raised $647 million in capital through a committed equity financing facility and increased its holdings from 12.5 million to 29.3 million HYPE tokens by the end of its fiscal year. It also reported holding 33.2 million tokens on September 8, 2026, and said it believes this represents the largest HYPE holding by a U.S.-listed company. The company described building, managing and optimizing its HYPE treasury as the focus of its business, and expects staking to generate recurring rewards.
The annual results provide financial context for this activity; the company said it had $149.9 million in cash and cash equivalents, with no debt, on June 30, 2026. It recorded $9.5 million in staking revenue and validator commissions during the 12 months ended on that date. Net income was $305.5 million for the same period. In the market, PURR closed at $9.62 on October 21 and $8.68 on October 22, according to EL7 data; market data for October 22 also showed a daily decline of $0.94, or 9.77%. This price movement preceded the announcement raising the authorization on October 23 and does not by itself prove that the price change was linked to the buyback decision.